The Food and Drug Administration (FDA) has approved Shorla Oncology‘s IMKELDI for the treatment of specific leukaemia cancer ...
Novo Nordisk Canada says in a news release Wednesday that Health Canada has given approval for the use of Wegovy – an ...
The European Commission’s decision is based on two Phase III trials where Tevimbra plus chemotherapy improved overall ...
The Brighterside of News on MSN21 小时
FDA-approved diabetes drug significantly slows down aging
Scientists from the Chinese Academy of Sciences (CAS) have uncovered compelling evidence suggesting that aging might be more ...
Rabbit Monoclonal Primary Antibody test as a companion diagnostic to assess HER2+ status in patients with BTC.
Researchers have discovered that a drug commonly used to treat hypertension can extend lifespan and slow down aging. The ...
A new therapy for brittle type 1 diabetes, the only treatment currently approved by the U.S. Food and Drug Administration, is ...
Sacral neuromodulation is an advanced therapy for people with bladder and bowel control issues that are not responding to ...
New data collected by the FDA has found that montelukast can bind to brain cells, which may explain the risk of mental health ...
Imatinib oral solution has gained FDA approval for the treatment of some cancers, including certain forms of leukemia.
See the new treatment that will break a Pfizer monopoly on a drug for heart disease.
With approval, acoramaidis (Attruby; BridgeBio Pharma) becomes the first agent with a label specifying near-complete ...